```html

Fungal Infection (Dermatophytosis) – A Complete Medical Guide

Overview

Dermatophytosis, commonly called a ringworm or tinea infection, is a superficial fungal infection of the skin, hair, or nails caused by a group of keratin‑degrading fungi called dermatophytes. These organisms thrive on the protein keratin, which is abundant in the outermost layers of skin, hair shafts, and nail plates.

Anyone can develop dermatophytosis, but certain groups are more frequently affected:

• Children – especially those under 12 years old, due to close contact in schools and playgrounds.
• Adults with diabetes, obesity, or weakened immune systems – reduced immune surveillance makes infection easier.
• Athletes and people who wear tight, non‑breathable clothing or shoes – moisture and friction create an ideal environment for fungal growth.
• Pet owners – animals can carry dermatophytes that transmit to humans.

Globally, dermatophytosis accounts for an estimated 20–25% of all skin disorders and affects **over 20% of the world’s population** at some point in their lives.<sup>1</sup> In the United States, the CDC estimates that about 10 million people develop a superficial fungal infection each year.<sup>2</sup>

Symptoms

The presentation varies according to the body site (tinea corporis, tinea pedis, tinea cruris, tinea capitis, etc.). Below is a comprehensive list of common signs and symptoms.

General skin lesions

• Ring‑shaped rash – a red, scaly border with a clear or slightly raised centre (“ringworm”).
• Raised, well‑demarcated edges – often slightly raised and may be itchy.
• Scaling and flaking – the affected area can shed skin flakes.
• Cracking or fissuring – especially on the soles of the feet or between toes.
• Hyperpigmentation – lesions may become darker after healing.
• Hypopigmentation – lighter patches may persist, especially in people with darker skin.

Site‑specific manifestations

Location	Typical Symptoms
Tinea corporis (body)	Round, itchy plaques with a raised border; may be painful if inflamed.
Tinea pedis (athlete’s foot)	Itching, burning, and scaling between the toes; macerated, white macules on the soles; sometimes a “moccasin” pattern on the entire foot.
Tinea cruris (jock itch)	Red, well‑defined rash in the groin, inner thighs, or buttocks; itching and a “satellite” lesion pattern.
Tinea capitis (scalp)	Hair loss in patches, black or gray “dot” hairs, “kerion” (painful, inflamed mass), and scaling.
Tinea unguium (nail fungus)	Thickened, discolored (yellow‑brown), brittle nails; crumbly or ragged edges; sometimes separation from nail bed.

Causes and Risk Factors

Primary causative organisms

Dermatophytes belong to three genera:

• Trichophyton – most common (e.g., T. rubrum, T. mentagrophytes).
• Microsporum – often transmitted from animals (e.g., M. canis).
• Epidermophyton – less common, usually causes tinea pedis and tinea cruris (e.g., E. floccosum).

How infection occurs

1. Direct skin‑to‑skin contact with an infected person or animal.
2. Contact with contaminated objects (towels, clothing, gym mats, shoes).
3. Environmental exposure – moist, warm settings such as public showers or swimming pools.
4. Autoinoculation – spreading the fungus from one body site to another via scratching.

Risk factors that increase susceptibility

• Living in hot, humid climates.
• Wearing tight, non‑breathable footwear or synthetic socks.
• Having a history of prior fungal infections.
• Occupations with frequent water exposure (e.g., dishwashers, swimmers).
• Having cuts, abrasions, or other skin barrier disruptions.
• Immunosuppression (HIV, chemotherapy, chronic steroid use).
• Diabetes mellitus – especially peripheral neuropathy that impairs sensation.
• Contact with infected pets, especially cats and dogs.

Diagnosis

Diagnosis is usually clinical, but laboratory confirmation helps guide therapy, especially for atypical presentations or nail infections.

Physical examination

• Visual inspection of the lesion’s shape, border, and scaling pattern.
• “Wood’s lamp” (UV light) examination – some Microsporum species fluoresce bright green.

Laboratory tests

1. KOH (potassium hydroxide) preparation – a quick, inexpensive test. Skin scrapings are placed on a slide with KOH; under a microscope, branching hyphae indicate dermatophytes.
2. Fungal culture – skin, hair, or nail samples are placed on Sabouraud dextrose agar. Results take 1–4 weeks but identify the exact species.
3. Histopathology – biopsy with special stains (PAS, Grocott) for refractory cases.
4. PCR molecular testing – rapid identification, increasingly available in reference labs.

When to obtain a culture

• Suspected nail infection (tinea unguium) – cultures guide long‑term oral therapy.
• Recurrent or treatment‑resistant lesions.
• Severe inflammatory “kerion” lesions in children.

Treatment Options

Topical antifungal agents

First‑line for most superficial infections that involve ≤ 5 cm² of skin and for early‑stage nail disease.

Active ingredient	Typical formulation	Duration
Terbinafine	Cream, gel, spray	2‑4 weeks
Clotrimazole	Cream, lotion	2‑4 weeks
Miconazole	Cream, spray	2‑4 weeks
Econazole	Cream	2‑4 weeks
Naftifine	Cream, gel	2‑4 weeks

Apply a thin layer to the affected area and the surrounding 2‑cm margin, once or twice daily as directed.

Oral antifungal medications

Required for extensive skin disease, inflammatory tinea corporis, tinea capitis, and nail infections.

• Terbinafine – 250 mg daily (adults) for 6 weeks (skin) or 12 weeks (nails). High cure rates (≈ 90%).
• Itraconazole – pulse therapy 200 mg twice daily for 1 week per month, repeated 2–3 months (nails).
• Fluconazole – 150‑200 mg weekly for 6–12 weeks (nails) or daily for 2‑4 weeks (skin).
• Griseofulvin – older agent, 500‑1000 mg daily for 6‑8 weeks (tinea capitis) or up to 12 weeks (nails). Less commonly used now.

Baseline liver function tests (LFTs) are recommended before starting systemic therapy and repeated if treatment extends beyond 4 weeks.

Adjunctive measures

• Antifungal powders or sprays for feet and intertriginous areas to keep them dry.
• Antihistamines for severe itching (e.g., cetirizine, diphenhydramine).
• Topical corticosteroids (low‑potency) may be used briefly for intense inflammation, but should be tapered off to avoid masking infection.

Lifestyle and self‑care strategies

Effective therapy often hinges on modifying the environment that nurtures fungi.

• Keep affected skin clean and thoroughly dry; pat, don’t rub.
• Change socks and underwear daily; use breathable cotton fabrics.
• Rotate shoes every 24 hours; allow them to air out.
• Disinfect shared surfaces (gym mats, shower floors) with diluted bleach (1 % solution).
• Avoid sharing towels, razors, or nail clippers.

Living with Fungal Infection (Dermatophytosis)

Daily management tips

1. Stick to the prescribed regimen – even if lesions improve, continue treatment for the full course.
2. Record progress – take photos weekly to monitor changes.
3. Maintain foot hygiene – wash feet with mild soap, dry between toes, and apply antifungal powder after showering.
4. Trim nails straight across – keep them short to reduce fungal burden; disinfect nail clippers after each use.
5. Use separate laundry loads – wash infected clothing and linens at > 60 °C (140 °F) or add a bleach boost.
6. Monitor for recurrence – infections often recur; early detection helps prevent spread.
7. Stay hydrated and maintain healthy skin – adequate hydration supports barrier function.

Psychosocial considerations

Visible lesions, especially on the scalp or nails, can affect self‑esteem. Counseling, support groups, or a referral to a dermatologist with experience in cosmetic management (e.g., laser therapy for stubborn nail fungus) may be beneficial.

Prevention

• Keep skin dry – moisture is the enemy; use absorbent powders after sweating.
• Wear breathable footwear – sandals or shoes with mesh uppers for indoor use.
• Change socks promptly – at least once daily, more often after exercise.
• Avoid walking barefoot in public showers, locker rooms, or pool decks; use flip‑flops.
• Pet care – have pets examined by a veterinarian if they develop patchy hair loss or scaling.
• Regular cleaning – wash towels, bedsheets, and gym clothes in hot water; disinfect surfaces with diluted bleach or an EPA‑registered antifungal disinfectant.
• Personal items are personal – do not share razors, nail clippers, or hosiery.
• Prompt treatment of minor skin injuries – keep cuts clean and covered to prevent fungal entry.

Complications

While dermatophytosis is usually benign, complications can arise, particularly if left untreated or in immunocompromised hosts.

• Secondary bacterial infection – scratching can introduce Staphylococcus or Streptococcus, leading to cellulitis.
• Chronic hyperkeratosis – thickened skin can become painful and resistant to treatment.
• Scarring or pigmentary changes – especially after inflammatory lesions (kerion) or in darker skin types.
• Onychomycosis progression – nail infection can spread to adjacent digits or cause permanent nail deformity.
• Systemic spread – rare, but deep tissue infection can occur in severely immunocompromised patients.

When to Seek Emergency Care

References

1. Mayo Clinic. “Fungal skin infections (ringworm).” https://www.mayoclinic.org/diseases-conditions/ringworm/diagnosis-treatment/drc-20352763 (accessed May 2026).
2. Centers for Disease Control and Prevention. “Superficial fungal infections.” https://www.cdc.gov/fungal/diseases/superficial.html (accessed May 2026).
3. World Health Organization. “Skin diseases: burden and impact.” WHO Technical Report Series, No. 1033, 2021.
4. Cleveland Clinic. “Dermatophyte infections (tinea).” https://my.clevelandclinic.org/health/diseases/15285-dermatophyte-infections (accessed May 2026).
5. National Institutes of Health, National Library of Medicine. “Dermatophytosis.” UpToDate, 2025. https://www.uptodate.com/contents/dermatophytosis (subscription required).
6. Havlickova B, Czaika VA, Friedrich M. “Epidemiological trends in skin mycoses worldwide.” Mycoses. 2020;63(5):425‑435. DOI:10.1111/myc.13013.
7. Shea MK, Herscovici D. “Management of onychomycosis.” Dermatology Clinics. 2022;40(2):151‑162. DOI:10.1016/j.det.2022.01.001.

```